✦ LIBER ✦

Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the italian oncology group for clinical research

✍ Scribed by Crinòc*, Lucio; Clerici, Maurizia; Figoli, Franco; Barduagni, Mario; Carlini, Paolo; Ceci, Guido; Cortesi, Enrico; Carpi, Amelia; Santini, Alessandra; Di Costanzo, Francesco; Boni, Corrado; Meacci, Marialuisa; Corgna, Enrichetta; Santucci, Antonella; Ballatori, Enzo; Tonato, Maurizio

Book ID: 122967941
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 463 KB
Volume: 12
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(95)00428-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Superiority of three-drug combination ch

Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: A randomized trial by the Italian oncology group for clinical research

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Superiority of three-drug combination ch

Superiority of three-drug combination chemotherapy vs cisplatin-etoposide in advanced non small cell lung cancer. A randomized trial of the Italian oncology group for clinical research

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 175 KB

27 Gemcitabine plus cisplatin versus eto

27 Gemcitabine plus cisplatin versus etoposide plus cisplatin in advanced non-small cell lung cancer: A randomized trial by the Spanish lung cancer group

✍ López Cabrerizo, M.P.; Cardenal, F.; Artal, A.; Lomas, M.; Alberola, V.; Massuti 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Chemotherapy of advanced non-small-cell

Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian oncology group for clinical research (G.O.I.R.C.)

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Cisplatin (CDDP)-etoposide VS DCCP-mitom

Cisplatin (CDDP)-etoposide VS DCCP-mitomycin-vindesine VS CDDP-mitomycin-iphosphamide in advanced non small cell lung cancer (NSCLC). A prospective randomized trial of the Italian oncology group for clinical research. (GOIRC)

✍ Crinò, L.; Clerici, M.; Figoli, F.; Carlini, P.; Ceci, G.; Cortesi, E.; Carpi, A 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 195 KB

First-Line Erlotinib Followed by Second-

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The TORCH Randomized Trial

✍ Gridelli, C.; Ciardiello, F.; Gallo, C.; Feld, R.; Butts, C.; Gebbia, V.; Maione 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 259 KB